Aventura Private Wealth’s Roivant Sciences ROIV Stock Holding History

Aventura Private Wealth’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.39K	Hold	124	–	–	﹤0.01%	706
2026 Q1	$3.44K	Hold	124	–	–	﹤0.01%	697
2025 Q4	$2.69K	Hold	124	–	–	﹤0.01%	663
2025 Q3	$1.88K	Hold	124	–	–	﹤0.01%	681
2025 Q2	$1.4K	Hold	124	–	–	﹤0.01%	660
2025 Q1	$1.25K	Hold	124	–	–	﹤0.01%	642
2024 Q4	$1.47K	Buy	+124	New	+$1.47K	﹤0.01%	609

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Aventura Private Wealth's ROIV Position: Q2 2026 in Review

Aventura Private Wealth held its Roivant Sciences (ROIV) position steady in Q2 2026 at 124 shares worth $4.39K. The position accounts for ﹤0.01% of the portfolio, ranked #706.

Aventura Private Wealth first reported a position in ROIV in Q4 2024 and has held it in 7 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

Aventura Private Wealth held 124 shares of Roivant Sciences worth $4.39K as of Q2 2026.
Aventura Private Wealth left its Roivant Sciences share count unchanged in Q2 2026.
Roivant Sciences made up ﹤0.01% of Aventura Private Wealth's portfolio in Q2 2026, its #706 holding.
Aventura Private Wealth first reported a position in Roivant Sciences in Q4 2024 and has held it in 7 quarters since.
498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Aventura Private Wealth's 13F filing for Q2 2026, filed 15 Jul 2026.